UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Details {2}
Sales, net	$ 9,812	$ 10,005	$ 29,475	$ 31,745
Cost of goods sold	4,208	4,203	12,738	12,925
Gross profit	5,604	5,802	16,737	18,820
Operating expense
Selling, general and administrative	2,826	2,287	7,320	7,464
Research & development	167	172	456	692
Total operating expense	2,993	2,459	7,776	8,156
Operating income	2,611	3,343	8,961	10,664
Other income	698	836	2,043	2,524
Income before provision for income taxes	3,309	4,179	11,004	13,188
Provision for income taxes	678	616	2,284	2,216
Net income	$ 2,631	$ 3,563	$ 8,720	$ 10,972
Earnings per share, basic	$ 0.82	$ 1.02	$ 2.68	$ 3.1
Earnings per common share (diluted)	$ 0.82	$ 1.02	$ 2.68	$ 3.1
Shares outstanding - basic	3,207	3,478	3,254	3,542
Shares outstanding - diluted	3,207	3,478	3,254	3,542
Foreign currency translation net of taxes of $0 in all periods	$ (376)	$ 1,432	$ 2,170	$ 769
Total comprehensive income	$ 2,255	$ 4,995	$ 10,890	$ 11,741